New scan could spot bladder cancer earlier
NCT ID NCT04897763
First seen Jan 10, 2026 · Last updated May 24, 2026 · Updated 20 times
Summary
This early study tested a new imaging agent called 89Zr-girentuximab to see if it can help detect non-muscle-invasive bladder cancer using PET/CT scans. Six adults with confirmed bladder cancer took part. The goal was to check safety and how well the scan shows cancer spots.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institut de cancerologie de l'Ouest
Saint-Herblain, 44805, France
Conditions
Explore the condition pages connected to this study.